 |
Top 35 medical and healthcare startups in Switzerland
Oct 12, 2024 | By Jason Kwon | 17 |
1
Funding: $268M
Basilea Pharmaceutica is a commercial stage biopharmaceutical company that develops and commercializes innovative medicines in the therapeutic area of anti-infectives
Basilea Pharmaceutica is a commercial stage biopharmaceutical company that develops and commercializes innovative medicines in the therapeutic area of anti-infectives
2
Funding: $214.7M
SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.
SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.
3
Funding: $101.8M
ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
4
Funding: $2.5B
Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. It is a unique biopharmaceutical company with world-class drug development experts working across multiple clinical and functional areas.
Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. It is a unique biopharmaceutical company with world-class drug development experts working across multiple clinical and functional areas.
5
Funding: $751.6M
ADC Therapeutics is focused on the development of proprietary Antibody Drug Conjugates (ADCs) for the treatment of both solid and hematological cancers. ADC Therapeutics employs monoclonal antibodies specific to particular tumor antigens conjugated to a novel class of highly potent pyrrolobenzodiazepine (PBD) -based warheads to selectively kill cancer cells.
ADC Therapeutics is focused on the development of proprietary Antibody Drug Conjugates (ADCs) for the treatment of both solid and hematological cancers. ADC Therapeutics employs monoclonal antibodies specific to particular tumor antigens conjugated to a novel class of highly potent pyrrolobenzodiazepine (PBD) -based warheads to selectively kill cancer cells.
6
Funding: $340.7M
MindMotionPro is a CE-Marked hospital based solution for early motor rehabilitation post-stroke. An engaging and motivational virtual reality rehabilitation program that supports individual recovery goal.
MindMotionPro is a CE-Marked hospital based solution for early motor rehabilitation post-stroke. An engaging and motivational virtual reality rehabilitation program that supports individual recovery goal.
7
Funding: $265.2M
Sophia Genetics aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning.
Sophia Genetics aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning.
8
Funding: $221.8M
Arvelle carries forward the European rights to cenobamate, an anti-epileptic drug for partial-onset seizures
Arvelle carries forward the European rights to cenobamate, an anti-epileptic drug for partial-onset seizures
9
Funding: $184M
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
10
Funding: $108.8M
Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.
Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.
